ALS Limited Stock

Equities

ALQ

AU000000ALQ6

Business Support Services

Delayed Australian S.E. 09:15:41 2024-07-21 pm EDT 5-day change 1st Jan Change
14.5 AUD +0.83% Intraday chart for ALS Limited +1.26% +12.84%
Sales 2025 * 2.94B 1.96B Sales 2026 * 3.15B 2.1B Capitalization 6.97B 4.66B
Net income 2025 * 314M 210M Net income 2026 * 354M 237M EV / Sales 2025 * 2.91 x
Net Debt 2025 * 1.57B 1.05B Net Debt 2026 * 1.5B 1B EV / Sales 2026 * 2.69 x
P/E ratio 2025 *
22.1 x
P/E ratio 2026 *
19.6 x
Employees -
Yield 2025 *
2.81%
Yield 2026 *
3.13%
Free-Float 97.54%
More Fundamentals * Estimated data
Dynamic Chart
1 day-0.76%
1 week+0.14%
Current month+2.64%
1 month-0.76%
3 months+10.28%
6 months+14.95%
Current year+11.91%
More quotes
1 week
14.13
Extreme 14.13
14.76
1 month
13.82
Extreme 13.82
14.76
Current year
11.75
Extreme 11.75
14.76
1 year
10.60
Extreme 10.6
14.76
3 years
9.96
Extreme 9.96
14.76
5 years
4.36
Extreme 4.36
14.76
10 years
2.93
Extreme 2.93
14.76
More quotes
Managers TitleAgeSince
Chief Executive Officer - 13-02-28
Director of Finance/CFO 57 Jan. 31
Investor Relations Contact - -
Members of the board TitleAgeSince
Director/Board Member 74 12-01-31
Chairman 69 15-07-31
Director/Board Member 63 23-06-06
More insiders
Date Price Change Volume
24-07-21 14.5 +0.83% 174 141
24-07-19 14.38 -0.76% 736,002
24-07-18 14.49 -1.43% 675,238
24-07-17 14.7 +1.94% 631,479
24-07-16 14.42 +0.70% 511,291

Delayed Quote Australian S.E., July 19, 2024 at 02:10 am EDT

More quotes
ALS Limited is an Australia-based company engaged in the provision of professional technical services, primarily in the areas of testing, measurement and inspection. The Company provides comprehensive testing solutions to clients in a range of industries around the world. The Company operates through two segments: Commodities and Life Sciences. Its Commodities segment provides assaying and analytical testing services and metallurgical services for mining and mineral exploration companies and provides specialist services to the coal industry, such as coal sampling, analysis and certification, formation evaluation services, tribology testing services and related analytical testing. The Life Sciences segment provides analytical testing data to assist consulting and engineering firms, industry, and governments around the world in making informed decisions about environmental, food and pharmaceutical, electronics, consumer products, and animal health.
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
14.38 AUD
Average target price
14.3 AUD
Spread / Average Target
-0.57%
Consensus